Biotech · Private company
Precision For Medicine
Track this companyFree. Adds Precision For Medicine to your Dealase workspace and tells you when its record changes.
Clinical trials61 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials6
- A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid TumorsPHASE1 · RECRUITING · started Jan 23, 2025ClinicalTrials.gov NCT06789172 · fetched Nov 12, 2026
- A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRDPHASE2 · COMPLETED · started Feb 1, 2022ClinicalTrials.gov NCT05414422 · fetched Nov 12, 2026
- Study to Establish the Diagnostic Performance of 18F Fluciclovine PET in Detecting Recurrent Brain MetastasesPHASE3 · COMPLETED · started Oct 26, 2020ClinicalTrials.gov NCT04410133 · fetched Nov 12, 2026
- Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE)PHASE2 · COMPLETED · started Aug 31, 2020ClinicalTrials.gov NCT04410367 · fetched Nov 12, 2026
- A Randomized Phase 1 Dose-Escalation Study of Subcutaneously(SC) Administered RUC-4PHASE1 · COMPLETED · started Feb 18, 2019ClinicalTrials.gov NCT03844191 · fetched Nov 12, 2026
- A Study of Melphalan Flufenamide (Melflufen) Plus Dexamethasone in Patients With Relapsed or Refractory Multiple MyelomaPHASE2 · COMPLETED · started Dec 28, 2016ClinicalTrials.gov NCT02963493 · fetched Nov 12, 2026